• Hereditary angioedema with normal C1 inhibitor function: Consensus of an international expert panel: B Zuraw, M.D., K Bork, M.D., K Binkley, M.D., A Banerji, M.D., S Christiansen, M.D., A Castaldo, M.P.A., A Kaplan, M.D., M Riedl, M.D., C Kirkpatrick, M.D., M Magerl, M.D., C Drouet, Ph.D., and M Cicardi, M.D. (Allergy Asthma Proc 33:S145–S156, 2012; doi:10.2500/aap.2012.33.3627)

• The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update M Maurer , M Magerl , I Ansotegui , E Aygören Pürsün, S Betschel , K Bork , T Bowen , H B Boysen, H Farkas , A Grumach , M Hide , C Katelaris , R Lockey, H Longhurst , W Lumry , I Martinez -Saguer , D Moldovan , A Nast , R Pawankar , P Potter, M Riedl , B Ritchie , L Rosenwasser , M Sánchez -Borges, Yuxiang Zhi , B Zuraw , T Craig. doi: 10.1111/all.13384

• Bork K, Wulff K, Witzke G, Hardt J. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy 2016; DOI: 10.1111/all.13076.

• Betschel et al. Allergy, Asthma & Clinical Immunology 2014, 10:50 http://www.aacijournal.com/content/10/1/50

• Bork K, Wulff K, Witzke G, Hardt J. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations. Allergy 2015; 70: 1004–1012.

• de Maat S, Björkqvist J, Suffritti C, Wiesenekker CP, Nagtegaal W, Koekman A, van Dooremalen S, Pasterkamp G, de Groot PG, Cicardi M, Renné T, Maas C, Plasmin is a natural trigger for bradykinin production in hereditary angioedema with Factor XII mutations, Journal of Allergy and Clinical Immunology (2016), doi: 10.1016/j.jaci.2016.02.021.

Para descargar el PDF del artículo
Angioedema hereditario con C1 inhibidor normal

Haga click aquí